Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick T Murray

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
JAMA|October 26, 2018
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical TrialPeter Pickkers, Ravindra L Mehta, Patrick T Murray, et al.
International Journal of Cardiology|February 24, 2022
Decongestion, kidney injury and prognosis in patients with acute heart failureYu Horiuchi, Nicholas Wettersten, Dirk J van Veldhuisen, et al.
ESC Heart Failure|November 3, 2022
Implications of worsening renal function before hospitalization for acute heart failureNicholas Wettersten, Stephen Duff, Yu Horiuchi, et al.
European Journal of Heart Failure|March 31, 2021
Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failureNicholas Wettersten, Yu Horiuchi, Dirk J van Veldhuisen, et al.
Intensive Care Medicine|December 11, 2019
Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 WorkgroupMichael Joannidis, Lui G Forni, Sebastian J Klein, et al.
BMJ Open|April 3, 2023
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injuryPeter Pickkers, Derek C Angus, Jacques Arend, et al.
Intensive Care Medicine|March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Intensive Care Medicine|January 3, 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 1, 2022
Effects of brain tissue oxygen (PbtO<sub>2</sub>) guided management on patient outcomes following severe traumatic brain injury: A systematic review and meta-analysisLeanne M C Hays, Andrew Udy, Alexios A Adamides, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2024
Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroupRinaldo Bellomo, Ghada Ankawi, Sean M Bagshaw, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
JAMA|October 26, 2018
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical TrialPeter Pickkers, Ravindra L Mehta, Patrick T Murray, et al.
International Journal of Cardiology|February 24, 2022
Decongestion, kidney injury and prognosis in patients with acute heart failureYu Horiuchi, Nicholas Wettersten, Dirk J van Veldhuisen, et al.
ESC Heart Failure|November 3, 2022
Implications of worsening renal function before hospitalization for acute heart failureNicholas Wettersten, Stephen Duff, Yu Horiuchi, et al.
European Journal of Heart Failure|March 31, 2021
Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failureNicholas Wettersten, Yu Horiuchi, Dirk J van Veldhuisen, et al.
Intensive Care Medicine|December 11, 2019
Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 WorkgroupMichael Joannidis, Lui G Forni, Sebastian J Klein, et al.
BMJ Open|April 3, 2023
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injuryPeter Pickkers, Derek C Angus, Jacques Arend, et al.
Intensive Care Medicine|March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Intensive Care Medicine|January 3, 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 1, 2022
Effects of brain tissue oxygen (PbtO<sub>2</sub>) guided management on patient outcomes following severe traumatic brain injury: A systematic review and meta-analysisLeanne M C Hays, Andrew Udy, Alexios A Adamides, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2024
Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroupRinaldo Bellomo, Ghada Ankawi, Sean M Bagshaw, et al.
Pageof 12